RYTM Rhythm Pharmaceuticals Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rhythm Pharmaceuticals Inc. market cap is $3.02B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Rhythm Pharmaceuticals Inc. 52 week high is $53.92 as of July 26, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rhythm Pharmaceuticals Inc. 52 week low is $17.65 as of July 26, 2024.

Rhythm Pharmaceuticals Inc. stock price today is $49.05.

Rhythm Pharmaceuticals Inc. stock price yesterday was $49.61.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rhythm Pharmaceuticals Inc.’s P/E ratio is -10.70.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rhythm Pharmaceuticals Inc. P/B ratio is 49.1135.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Rhythm Pharmaceuticals Inc.'s EBITDA is -9.31.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rhythm Pharmaceuticals Inc. 50-day moving average is $42.42.

Rhythm Pharmaceuticals Inc. has 226 employees.